サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1676193

高分解能溶融分析の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global High-Resolution Melting Analysis Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 133 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
高分解能溶融分析の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 133 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

高分解能溶融分析の世界市場規模は、2024年の4億843万米ドルから2033年には8億5,962万米ドルに成長し、2026～2033年の予測期間中に8.62％の堅調な年間平均成長率（CAGR）を示すと予測されています。

高分解能融解（HRM）分析市場は、精密な遺伝子分析と分子診断の需要が高まるにつれて大きく成長する見込みです。HRMはDNA変異の分析に用いられる強力な技術であり、研究、臨床診断、個別化医療への応用に不可欠な迅速かつ正確な結果を記載しています。遺伝性疾患の有病率の増加と効果的なスクリーニング方法の必要性が、様々な医療現場でのHRM技術の採用を促進しています。研究者や臨床医が遺伝的変異の理解を深めようとする中で、HRMは分子生物学ツールキットの重要なツールとして台頭しつつあります。

技術の進歩は高分解能融解分析の能力を押し上げ、より身近で効率的なものとなっています。装置とソフトウェアの革新は、HRMの感度と特異性を高め、微妙な遺伝子変異の検出をも可能にしています。さらに、HRMと次世代シークエンシング技術との統合により、その応用範囲が拡大し、以前は不可能であった包括的なゲノム分析が可能になりつつあります。ゲノミクスのセグメントが進化し続けるにつれて、HRMのような信頼性の高い高性能分析法に対する需要は増大し、HRMは現代の遺伝子研究の要として位置づけられると予想されます。

さらに、個別化医療への注目の高まりが、HRM分析市場を前進させる可能性が高いです。医療が個人の遺伝子プロファイルによるオーダーメイド治療へとシフトするにつれ、遺伝的変異を迅速かつ正確に評価する能力が最も重要になります。がん診断や感染症検出など、さまざまな用途におけるHRMの臨床的有用性を裏付ける調査結果が増加していることから、HRMの採用がさらに加速されると予想されます。結論として、高分解能融解分析市場は、技術革新、精密医療の需要、医療における遺伝子分析の用途の拡大が原動力となり、目覚ましい成長を遂げようとしています。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察を顧客に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます。

市場概要：市場概要：定義、分類、産業の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主要促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場参入企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を記載しています。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域による市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネス機会を理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象セグメントを特定します。将来の市場開拓と成長展望に関する洞察を記載しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 高分解能融解分析産業分析

  • イントロダクション-市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原料分析
    • 原料リスト
    • 原料メーカー一覧
    • 主要原料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 高分解能融解分析の世界市場分析：製品タイプ別

  • 製品タイプ別概要
  • 製品タイプ別過去・予測データ分析
  • 試薬・消耗品
  • 装置
  • ソフトウェア

第6章 高分解能融解分析の世界市場分析：用途別

  • 用途別概要
  • 用途別過去・予測データ分析
  • SNPジェノタイピング
  • 変異探索
  • エピジェネティクス
  • 種の同定
  • その他

第7章 高分解能融解分析の世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • エンドユーザー別過去・予測データ分析
  • 研究所
  • 製薬・バイオテクノロジー企業
  • 学術・研究機関
  • その他

第8章 高分解能融解分析の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第9章 高分解能溶融分析企業の競合情勢

  • 高分解能溶融分析市場の競合
  • 提携・協力・契約
  • 合併・買収
  • 新製品の発売
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Qiagen N.V.
  • Agilent Technologies Inc.
  • Illumina Inc.
  • Merck KGaA
  • Promega Corporation
  • BioMeRieux S.A.
  • Takara Bio Inc.
  • Sigma-Aldrich Corporation
  • Canon BioMedical Inc.
  • Idaho Technology Inc.
  • Premier Biosoft
  • Zymo Research Corporation
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product Type (USD MN)
  • Reagents And Consumables Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • SNP Genotyping Market Sales By Geography (USD MN)
  • Mutation Discovery Market Sales By Geography (USD MN)
  • Epigenetics Market Sales By Geography (USD MN)
  • Species Identification Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-User (USD MN)
  • Research Laboratories Market Sales By Geography (USD MN)
  • Pharmaceutical And Biotechnology Companies Market Sales By Geography (USD MN)
  • Academic And Research Institutes Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global High-Resolution Melting Analysis Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of High-Resolution Melting Analysis Report
  • Market Research Process
  • Market Research Methodology
  • Global High-Resolution Melting Analysis Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product Type (USD MN)
  • Reagents And Consumables Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • SNP Genotyping Market Sales By Geography (USD MN)
  • Mutation Discovery Market Sales By Geography (USD MN)
  • Epigenetics Market Sales By Geography (USD MN)
  • Species Identification Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-User (USD MN)
  • Research Laboratories Market Sales By Geography (USD MN)
  • Pharmaceutical And Biotechnology Companies Market Sales By Geography (USD MN)
  • Academic And Research Institutes Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR112111199

Global High-Resolution Melting Analysis Market size is anticipated to grow from USD 408.43 Million in 2024 to USD 859.62 Million by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 8.62% during the forecast period of 2026 to 2033.

The high-resolution melting (HRM) analysis market is poised for significant growth as the demand for precise genetic analysis and molecular diagnostics escalates. HRM is a powerful technique used to analyze DNA variations, providing rapid and accurate results that are essential for applications in research, clinical diagnostics, and personalized medicine. The increasing prevalence of genetic disorders and the need for effective screening methods are driving the adoption of HRM technology across various healthcare settings. As researchers and clinicians seek to enhance their understanding of genetic variations, HRM is emerging as a vital tool in the molecular biology toolkit.

Technological advancements are propelling the capabilities of high-resolution melting analysis, making it more accessible and efficient. Innovations in instrumentation and software are enhancing the sensitivity and specificity of HRM, allowing for the detection of even subtle genetic variations. Furthermore, the integration of HRM with next-generation sequencing technologies is expanding its applications, enabling comprehensive genomic analyses that were previously unattainable. As the field of genomics continues to evolve, the demand for reliable and high-throughput analysis methods like HRM is expected to grow, positioning it as a cornerstone of modern genetic research.

Additionally, the increasing focus on personalized medicine is likely to drive the HRM analysis market forward. As healthcare shifts towards tailored treatment approaches based on individual genetic profiles, the ability to quickly and accurately assess genetic variations becomes paramount. The growing body of research supporting the clinical utility of HRM in various applications, including cancer diagnostics and infectious disease detection, is expected to further accelerate its adoption. In conclusion, the high-resolution melting analysis market is set for remarkable growth, driven by technological innovation, the demand for precision medicine, and the expanding applications of genetic analysis in healthcare.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

  • Reagents And Consumables
  • Instruments
  • Software

By Application

  • SNP Genotyping
  • Mutation Discovery
  • Epigenetics
  • Species Identification
  • Others

By End-User

  • Research Laboratories
  • Pharmaceutical And Biotechnology Companies
  • Academic And Research Institutes
  • Others
  • COMPANIES PROFILED
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Qiagen N.V.
  • Agilent Technologies Inc.
  • Illumina Inc.
  • Merck KGaA
  • Promega Corporation
  • bioMerieux S.A.
  • Takara Bio Inc.
  • Sigma-Aldrich Corporation
  • Canon BioMedical Inc.
  • Idaho Technology Inc.
  • Premier Biosoft
  • Zymo Research Corporation
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. HIGH-RESOLUTION MELTING ANALYSIS INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-User
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HIGH-RESOLUTION MELTING ANALYSIS MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data Analysis By Product Type
  • 5.3. Reagents And Consumables Historic and Forecast Sales By Regions
  • 5.4. Instruments Historic and Forecast Sales By Regions
  • 5.5. Software Historic and Forecast Sales By Regions

6. GLOBAL HIGH-RESOLUTION MELTING ANALYSIS MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. SNP Genotyping Historic and Forecast Sales By Regions
  • 6.4. Mutation Discovery Historic and Forecast Sales By Regions
  • 6.5. Epigenetics Historic and Forecast Sales By Regions
  • 6.6. Species Identification Historic and Forecast Sales By Regions
  • 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL HIGH-RESOLUTION MELTING ANALYSIS MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-User
  • 7.2. Historical and Forecast Data Analysis By End-User
  • 7.3. Research Laboratories Historic and Forecast Sales By Regions
  • 7.4. Pharmaceutical And Biotechnology Companies Historic and Forecast Sales By Regions
  • 7.5. Academic And Research Institutes Historic and Forecast Sales By Regions
  • 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL HIGH-RESOLUTION MELTING ANALYSIS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE HIGH-RESOLUTION MELTING ANALYSIS COMPANIES

  • 9.1. High-Resolution Melting Analysis Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF HIGH-RESOLUTION MELTING ANALYSIS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Thermo Fisher Scientific Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Bio-Rad Laboratories Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. F. Hoffmann-La Roche Ltd.
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Qiagen N.V.
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Agilent Technologies Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Illumina Inc.
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Merck KGaA
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Promega Corporation
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. BioMéRieux S.A.
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Takara Bio Inc.
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Sigma-Aldrich Corporation
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Canon BioMedical Inc.
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Idaho Technology Inc.
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments
  • 10.16. Premier Biosoft
    • 10.16.1 Company Overview
    • 10.16.2 Company Revenue
    • 10.16.3 Products
    • 10.16.4 Recent Developments
  • 10.17. Zymo Research Corporation
    • 10.17.1 Company Overview
    • 10.17.2 Company Revenue
    • 10.17.3 Products
    • 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies